Skip to main content
. Author manuscript; available in PMC: 2021 May 27.
Published in final edited form as: J Gastroenterol. 2020 Jan 13;55(5):523–532. doi: 10.1007/s00535-020-01663-1

Fig. 3.

Fig. 3

Cumulative incidence of persistent alkaline phosphatase change (initial: The initial persistent SAP group change defined by the first occurrence of 2 or more SAP values measured at least 3 months apart that differed from baseline group). a Individuals with normal alkaline phosphatase at diagnosis who subsequently develop an abnormal alkaline phosphatase; b individuals with an abnormal alkaline phosphatase at diagnosis who subsequently develop a normal alkaline phosphatase; c individuals with an alkaline phosphatase ≥ 1.5 times the upper limit of normal at diagnosis who subsequently develop an alkaline phosphatase value below this threshold